.

Emergent Biosolutions reported $793.6M in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
ALKERMES ALKS:US 291.54M 634K
Alnylam Pharmaceuticals ALNY:US $ 677.72M 1.01M
Amarin AMRN:US $ 0M 0M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Chimerix CMRX:US $ 0 0
Emergent Biosolutions EBS:US $ 793.6M 7.9M
Exact Sciences EXAS:US $ 2240.24M 46.96M
Glaxosmithkline GSK:US $ 18784M 10442M
Intercept Pharmaceuticals ICPT:US $ 713.86M 3.03M
IONIS PHARMACEUT IONS:US $ 1248.4M 0.47M
Ironwood Pharmaceuticals IRWD:US $ 395.45M 0.4M
JAZZ PHA JAZZ:US $ 5990M 2.87M
Lonza Group LONN:SW 1.95B 287M
Moderna Inc MRNA:US $ 641M 5M
Nektar Therapeutics NKTR:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 169M 208.7M
Opko Health OPK:US $ 217.74M 1.39M
Pacira Pharmaceuticals PCRX:US $ 721.88M 7.86M
Ptc Therapeutics PTCT:US $ 981.44M 5.79M
Sarepta Therapeutics SRPT:US $ 1100.87M 2.03M
Seattle Genetics SGEN:US $ 0M 0M
Teva Pharmaceutical Industries TEVA:US $ 20363M 477M
United Therapeutics UTHR:US $ 800M 0M
Xoma XOMA:US $ 0 0